COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA. (2020). Voprosy Onkologii, 66(2), 109-119. https://doi.org/10.37469/0507-3758-2020-66-2-109-119